Multi-Substituted Insulins
    63.
    发明申请
    Multi-Substituted Insulins 有权
    多取代胰岛素

    公开(公告)号:US20140228285A1

    公开(公告)日:2014-08-14

    申请号:US14126215

    申请日:2012-06-14

    IPC分类号: C07K14/62

    摘要: The present invention regards an insulin derivative comprising at least 2 albumin binding moieties, wherein said albumin binding moieties comprise fatty diacid substitutions and a method for preparing such an insulin derivative by acylation and/or reductive alkylation. The present invention also concern a pharmaceutical comprising such an insulin derivative.

    摘要翻译: 本发明涉及包含至少2个白蛋白结合部分的胰岛素衍生物,其中所述白蛋白结合部分包含脂肪二酸取代和通过酰化和/或还原烷基化制备这种胰岛素衍生物的方法。 本发明还涉及包含这种胰岛素衍生物的药物。

    Insulin derivatives
    65.
    发明授权
    Insulin derivatives 有权
    胰岛素衍生物

    公开(公告)号:US08476228B2

    公开(公告)日:2013-07-02

    申请号:US13273659

    申请日:2011-10-14

    IPC分类号: A61K38/28 C07K14/62

    CPC分类号: A61K38/28 C07K14/62

    摘要: The present invention relates to insulin derivatives having a side chain attached either to the α-amino group of the N-terminal amino acid residue of the B chain or to the ε-amino group of a Lys residue present in the B chain of the parent insulin via an amide bond which side chain comprises at least one aromatic group; at least one free carboxylic acid group or a group which is negatively charged at neutral pH, a fatty acid moiety with 4 to 22 carbon atoms in the carbon chain; and possible linkers which link the individual components in the side chain together via amide bonds.

    摘要翻译: 本发明涉及具有侧链连接到B链的N末端氨基酸残基的α-氨基或母体B链中存在的Lys残基的ε-氨基的胰岛素衍生物 胰岛素通过酰胺键,该侧链包含至少一个芳族基团; 至少一个游离羧酸基团或在中性pH下带负电荷的基团,碳链中具有4-22个碳原子的脂肪酸部分; 以及通过酰胺键将侧链中各个组分连接在一起的可能接头。

    Protease Stabilized, Pegylated Insulin Analogues
    67.
    发明申请
    Protease Stabilized, Pegylated Insulin Analogues 审中-公开
    蛋白酶稳定化,聚乙二醇化胰岛素类似物

    公开(公告)号:US20100216691A1

    公开(公告)日:2010-08-26

    申请号:US12669189

    申请日:2008-07-09

    申请人: Peter Madsen

    发明人: Peter Madsen

    CPC分类号: A61K38/28 A61K47/60 C07K14/62

    摘要: Novel PEGylated insulin analogues exhibiting resistance towards proteases can, effectively, be administered pulmonary or orally. The insulin analogues contain B25H and A14E or A14H. The PEGylation is at B29K.

    摘要翻译: 对蛋白酶具有抗性的新型聚乙二醇化胰岛素类似物可以有效地被肺或口服给药。 胰岛素类似物含有B25H和A14E或A14H。 PEG化处于B29K。